Article
Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction Treatment
2 Oct 2020
Abstract excerpt
Ischemic heart disease and myocardial infarction remain leading causes of mortality worldwide. Existing myocardial infarction treatments are incapable of fully repairing and regenerating the infarcted myocardium. Stem cell transplantation therapy has demonstrated promising results in improving heart function following myocardial infarction. However, poor cell survival and low engraftment at the harsh and hostile...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
